Newsroom
Sorted by: Latest
-
Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier™ Platform at AACR Annual Meeting 2026
BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced that it will present preclinical data on its FMC-242 program, as well as advances from its AI-powered Frontier™ Platform, at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April...
-
NuORDER by Lightspeed annuncia una collaborazione con Boozt per promuovere gli acquisti basati sui dati e potenziare la crescita
MONTREAL--(BUSINESS WIRE)--NuORDER by Lightspeed annuncia un nuovo rapporto strategico con Boozt, un rivenditore digitale nordico leader nel settore, per integrare un maggiore volume di informazioni sugli acquisti nelle sue operazioni e supportare la costante crescita di NuORDER nei mercati europei. La collaborazione sostituisce i fogli di lavoro frammentari e i flussi di lavoro manuali con una piattaforma centralizzata che connette gli assortimenti, gli ordini e i dati relativi ai prodotti, mi...
-
Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced an upcoming poster presentation of initial clinical data from the FORTRESS study of NG-350A, an oncolytic immunotherapy for the treatment of mismatch repair-proficient (pMMR) locally advanced rectal cancer (LARC), at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego. The ongoing...
-
Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026...
-
NuORDER by Lightspeed verkündet Partnerschaft mit Boozt zur Förderung von dateninformierten Käufen und Wachstum
MONTREAL--(BUSINESS WIRE)--NuORDER by Lightspeed verkündet eine neue strategische Beziehung mit Boozt, einem führenden nordischen digitalen Einzelhändler, um mehr Kaufintelligenz in seine Abläufe zu integrieren und das stetige Wachstum von NuORDER in europäischen Märkten zu fördern. Im Rahmen der Kooperation werden fragmentierte Tabellenkalkulationen und manuelle Arbeitsabläufe durch eine zentralisierte Plattform ersetzt, die Sortimente, Bestellungen und Produktdaten verknüpft und auf diese Wei...
-
NuORDER by Lightspeed annonce un partenariat avec Boozt pour dynamiser les achats orientés données afin de stimuler la croissance
MONTRÉAL--(BUSINESS WIRE)--NuORDER by Lightspeed annonce un nouveau partenariat stratégique avec Boozt, un important distributeur numérique nordique, afin d'intégrer davantage d'informations sur ses achats et soutenir la croissance continue de NuORDER sur les marchés européens. Cette collaboration remplace les feuilles de calcul ventilées et les workflows manuels par une plateforme centralisée qui relie les assortiments, commandes et données produits, améliorant ainsi la visibilité du processus...
-
NuORDER by Lightspeed kondigt een partnerschap met Boozt aan om door data geïnformeerd kopen te bevorderen teneinde groei aan te drijven
MONTREAL--(BUSINESS WIRE)--NuORDER by Lightspeed kondigt een nieuwe strategische relatie aan met Boozt, een vooraanstaande Scandinavische digitale retailer, om meer koopinformatie in haar activiteiten te integreren en om NuORDER’s continue groei in Europese markten te ondersteunen. De samenwerking vervangt gefragmenteerde spreadsheets en handmatige workflows door een gecentraliseerd platform dat assortimenten, orders en productgegevens verbindt om de zichtbaarheid in Boozt’s koopproces te verho...
-
Sixth Street Specialty Lending, Inc. Provides a Letter to Stakeholders
NEW YORK--(BUSINESS WIRE)--Sixth Street Specialty Lending, Inc. (NYSE: TSLX, or the “Company”) today sent the following letter to its stakeholders. Please view a printable version of the letter here....
-
INVESTOR ALERT: Camping World Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
SAN DIEGO--(BUSINESS WIRE)--The Camping World complaint alleges that Camping World overstated its ability to “surgically manage [its] inventory” to optimize profit....
-
New HEAL Collaborative Analysis Reveals 340B Hospitals Increase Hospital Assets While Reducing Patient Care Spending
WASHINGTON--(BUSINESS WIRE)--A new state-by-state analysis released today by HEAL Collaborative provides further insight into how hospitals participating in the 340B program are allocating resources. The study, titled "The 340B Drug Pricing Program by State: How Covered Entities Are Failing to Invest in Patient Care," was conducted by Magnolia Market Access and provides the first detailed look at how hospitals participating in the federal 340B drug discount program are utilizing program revenue...